Please login to the form below
Azithromycin
This page shows the latest Azithromycin news and features for those working in and with pharma, biotech and healthcare.
GSK to submit drug application for new antibiotic to US FDA
An additional study, EAGLE-1, is comparing the efficacy and safety of two oral doses of gepotidacin to a regimen based on an intramuscular dose of ceftriaxone and oral azithromycin in
Latest news
-
Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
In January, the PRINCIPLE study also found that the commonly-used antibiotics azithromycin and doxycycline are not generally effective in certain patients with early COVID-19.
-
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
The UK-based PRINCIPLE study has found that the commonly-used antibiotics azithromycin and doxycycline are not generally effective in certain patients with early COVID-19. ... up. There was also no evidence that azithromycin reduced COVID-19-associated
-
FDA grants emergency authorisation to chloroquine for COVID-19
This data supports earlier preliminary results from a small study of hydroxychloroquine in combination with the antibiotic azithromycin, and as a monotherapy. ... Although the drug was effective on its own, when added to the antibiotic azithromycin,
-
Novartis donates malaria drug for COVID-19 clinical trials
Although the drug was effective on its own, when added to the antibiotic azithromycin, hydroxycholoroquine was found to produce a superior response, by a significant margin. ... Analysts from Dawson James Securities concluded that "hydroxychloroquine
-
GSK takes new-class antibiotic into phase 3 for serious infections
to the recommended first-choice treatment – a combination of azithromycin and ceftriaxone. ... EAGLE-1 will compare gepotidacin – a triazaacenaphthylene bacterial topoisomerase inhibitor developed in collaboration with US federal agencies – to the
More from news
Approximately 1 fully matching, plus 18 partially matching documents found.
Latest Intelligence
-
As COVID-19 takes over the world, biopharma fights back
An earlier study of 24 COVID-19 patients, also conducted by Raoult, found that within six days of taking hydroxychloroquine and the antibiotic azithromycin, the symptoms of the virus disappeared in
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
